Psychotic Disorders - Israel | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$44.92m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.65%, resulting in a market volume of US$46.41m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$330.40 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Israel is experiencing steady growth due to several factors. Customer preferences in Israel are shifting towards more personalized and holistic treatment options, which is driving the demand for innovative therapies. Additionally, the local special circumstances and underlying macroeconomic factors are contributing to the development of the market.Customer preferences in Israel are increasingly focused on personalized and holistic treatment options for psychotic disorders. Patients are seeking therapies that not only address the symptoms of their condition but also take into account their individual needs and preferences. This shift in customer preferences is driving the demand for innovative therapies that offer a more tailored approach to treatment. As a result, pharmaceutical companies are investing in research and development to create new drugs and therapies that meet these evolving customer demands.In addition to customer preferences, several trends in the market are contributing to its development. One trend is the increasing use of digital health technologies in the treatment of psychotic disorders. Telemedicine and mobile health applications are being utilized to provide remote consultations, monitor patient progress, and deliver personalized treatment plans. This trend is particularly relevant in Israel, where there is a high level of technological innovation and a strong emphasis on digital health solutions.Another trend in the market is the growing awareness and understanding of mental health issues in Israel. There is a greater recognition of the importance of early intervention and treatment for psychotic disorders, leading to increased efforts to identify and diagnose these conditions at an earlier stage. This trend is driving the demand for diagnostic tools and screening methods that can accurately detect psychotic disorders in their early stages, allowing for more effective treatment and management.Local special circumstances in Israel are also contributing to the development of the Psychotic Disorders market. Israel has a well-established healthcare system that provides comprehensive coverage for mental health services, including treatment for psychotic disorders. This accessibility to healthcare services ensures that patients have access to the necessary treatments and therapies, which in turn drives the demand for these products.Underlying macroeconomic factors, such as a growing economy and an aging population, are also contributing to the development of the market. As the economy grows, individuals have more disposable income to spend on healthcare services, including treatments for psychotic disorders. Additionally, the aging population in Israel is increasing the prevalence of mental health conditions, including psychotic disorders, leading to a greater demand for treatments and therapies.In conclusion, the Psychotic Disorders market in Israel is developing due to shifting customer preferences towards personalized and holistic treatment options, as well as the adoption of digital health technologies. The growing awareness and understanding of mental health issues, along with the accessibility of healthcare services, are also contributing to the market's development. Furthermore, underlying macroeconomic factors, such as a growing economy and an aging population, are driving the demand for treatments and therapies for psychotic disorders.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.